Japan prosecutors arrest ex-Novartis employee over data

Prosecutors on Wednesday arrested a former employee of the Japanese unit of Swiss pharmaceutical giant Novartis for allegedly manipulating research data to exaggerate the benefits of a popular blood-pressure drug.

Nobuo Shirahashi, 63, was arrested for allegedly falsifying data in clinical studies that were then used to promote the blood-pressure drug Valsartan.

Prosecutors raided the offices of Novartis Pharma KK in Tokyo after a university said the data may be skewed.

The studies suggested the drug—sold under the name Diovan in Japan, and licensed for use in more than 100 countries—could help prevent strokes and angina.

The firm used data from the studies to market its , playing up its supposed additional benefits.

There is no suggestion that Diovan is ineffective in combating blood pressure problems.

The pharmaceutical giant's Japan unit has also been embroiled in another scandal in which it was alleged possible side effects of leukaemia treatments had not been properly disclosed.

In April, Novartis replaced top executives at its Japanese arm over the allegations.

Under Japan's law, anyone found guilty of exaggerating advertising can face up to two years in prison or a fine of as much as two million yen ($19,000).

add to favorites email to friend print save as pdf

Related Stories

Japan prosecutors raid Novartis over drug ad scandal

Feb 19, 2014

Japanese prosecutors on Wednesday raided the offices of the local arm of Swiss pharmaceutical giant Novartis over alleged exaggerated advertising for a popular blood-pressure drug, local media said.

Japan files criminal complaint against Novartis arm

Jan 09, 2014

Japan's health ministry on Thursday filed a criminal complaint against the local arm of Swiss pharmaceutical giant Novartis over alleged exaggerated advertising for a popular blood-pressure drug, the company said.

Japan to file criminal complaint against Novartis (Update)

Jan 07, 2014

Japan's health ministry plans to file a criminal complaint against the local arm of Swiss pharmaceutical giant Novartis over alleged exaggerated advertising for a popular blood-pressure drug, an official said Wednesday.

Japan to seek criminal prosecution of Novartis

Dec 18, 2013

Japan's health ministry intends to file a criminal complaint against the local arm of Swiss pharmaceutical giant Novartis over alleged fabrication of drugs data, a report said Wednesday.

Recommended for you

Most US babies get their vaccines, CDC says

23 hours ago

(HealthDay)—The vast majority of American babies are getting the vaccines they need to protect them from serious illnesses, federal health officials said Thursday.

Expression of privilege in vaccine refusal

Aug 27, 2014

Not all students returning to school this month will be up to date on their vaccinations. A new study conducted by Jennifer Reich, a researcher at the University of Colorado Denver, shows that the reasons why children may ...

User comments